Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Takako Wakeda"'
Publikováno v:
Tumori Journal. 106:95-100
Background: Cancer treatment causes various skin appearance changes, which affect quality of life (QoL) in patients with cancer. We examined whether camouflage makeup improves QoL in these patients. Methods: Skindex-16 and visual analogue scale score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a395176663a1feb593f6777aa03f59bb
https://doi.org/10.1177/0300891619867844
https://doi.org/10.1177/0300891619867844
Autor:
Yoichi Takaue, Yuji Heike, Miho Kaida, Takako Wakeda, Chigusa Morizane, Yuriko Morita-Hoshi, Atsuko Soeda, Hideki Ueno, Yuni Yamaki, Shunsuke Kondo, Yasushi Kojima, Takuji Okusaka, Masafumi Ikeda
Publikováno v:
Journal of Immunotherapy. 34:92-99
An open-labeled, dose-escalation phase 1 trial of Wilms tumor 1 (WT1) vaccine and gemcitabine (GEM) combination therapy for patients with advanced pancreatic cancer or biliary tract cancer was performed. The primary end point was evaluation of toxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382ad0182a1790324f4631e82430c5e1
https://doi.org/10.1097/cji.0b013e3181fb65b9
https://doi.org/10.1097/cji.0b013e3181fb65b9
Autor:
Yasushi Kojima, Yuni Yamaki, Chigusa Morizane, Yuriko Morita-Hoshi, Takuji Okusaka, Miho Kaida, Takako Wakeda, Yuji Heike, Masafumi Ikeda, Shunsuke Kondo, Atsuko Soeda, Hideki Ueno
Publikováno v:
Japanese Journal of Clinical Oncology. 40:1184-1188
The skin toxicity of vaccine therapy at injection sites is generally limited to Grades 1-2 due to the nature of their function. We experienced two cases of severe and prolonged local adverse effects in 25 patients following a Phase I study of gemcita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262ba92e714285ff60baaeac076fca9c
https://doi.org/10.1093/jjco/hyq112
https://doi.org/10.1093/jjco/hyq112
Autor:
Takako Wakeda, Yuji Heike
Publikováno v:
Journal of Clinical Oncology. 34:259-259
259 Background: Cancer therapy causes various appearance changes, such as chemotherapy-induced alopecia and skin pigmentation. These events decrease cancer survivors’ QoL (quality of life), and sometimes deprive them of social life and work opportu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb5f854ac610c402d644c4c949e41d4c
https://doi.org/10.1200/jco.2016.34.26_suppl.259
https://doi.org/10.1200/jco.2016.34.26_suppl.259
Autor:
Takahiro Ochiya, Yoshinori Ikarashi, Kazunori Aoki, Hitoshi Nakagama, Yuji Heike, Takako Wakeda, Takahiro Yamazaki, Sung-Won Kim, Robert M. Hoffman, Yoichi Takaue
Publikováno v:
Immunology letters. 144(1-2)
Visualizing the in vivo dynamics of individual donor cells after allogeneic hematopoietic stem cell transplantation (HSCT) will enable deeper understanding of the process of graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL). In this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143436df3e900115ec3c0f75fbcf9258
https://pubmed.ncbi.nlm.nih.gov/22426442
https://pubmed.ncbi.nlm.nih.gov/22426442
Autor:
Keiichirou Tada, Kazuo Shirakawa, Yoshihiro Uchida, Takako Wakeda, Kotoe Nishioka, Hajime Kanauchi, Yasuko Kikuchi, Takayoshi Niwa
Publikováno v:
The Breast. 24:S40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4692fa5002d041678f89ca250dd0c985
https://doi.org/10.1016/s0960-9776(15)30066-7
https://doi.org/10.1016/s0960-9776(15)30066-7
Autor:
Chigusa Morizane, Y. Morita-Hoshi, Yuji Heike, H. Ueno, Y. Yamaki, Takako Wakeda, M. Kaida, A. Soeda, Shunsuke Kondo, Takuji Okusaka
Publikováno v:
Journal of Clinical Oncology. 28:e13049-e13049
e13049 Background: WT1 is expressed in various kinds of cancers and serves as a potent antigen for cancer immunotherapy. Methods: We performed a clinical phase I trial of gemcitabine (GEM) and WT1 vaccine combination therapy for advanced pancreatic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3b9ea553ade34059f48cd0cd5173749
https://doi.org/10.1200/jco.2010.28.15_suppl.e13049
https://doi.org/10.1200/jco.2010.28.15_suppl.e13049